Susceptibility genetic variants in Hungarian morbus Crohn and ulcerative colitis patients;Hajlamosító gének vizsgálata magyar morbus Crohn- és colitis ulcerosás betegpopulációban

Orvosi Hetilap

Volumn 150, Issue 2, 2009, Pages 81-88

  Magyari, Lili ^a   Melegh, Béla ^a,b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b NONE   (Hungary)

Author keywords

Crohn's disease; Infl ammatory bowel disease; Ulcerative colitis

Indexed keywords

CARRIER PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 23 RECEPTOR; SLC22A4 PROTEIN; SLC22A5 PROTEIN; UNCLASSIFIED DRUG; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR; LEUKOCYTE ANTIGEN; NOD2 PROTEIN, HUMAN; ORGANIC CATION TRANSPORTER; SLC22A4 PROTEIN, HUMAN; SLC22A5 PROTEIN, HUMAN;

CHILD; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; GENE MUTATION; GENE SEQUENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS; ADULT; AGED; ARTICLE; DNA SEQUENCE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED;

ADULT; AGED; ANTIGENS, CD; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; HUNGARY; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; ORGANIC CATION TRANSPORT PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, INTERLEUKIN; SEQUENCE ANALYSIS, DNA;

EID: 60749086043     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2009.28445     Document Type: Review

References (48)

1. Danese, S., Fiocchi, C.: Etiopathogenesis of infl ammatory bowel diseases. World J. Gastroenterol., 2006, 12, 4807-4812.
2. Pena, A. S.: Contribution of genetics to a new vision in the understanding of infl ammatory bowel disease. World J. Gast roenterol., 2006, 12, 4784-4787.
3. Gazouli, M., Mantzaris, G., Archimandritis, A. J. és mtsai: Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease. World J. Gast roenterol., 2005, 11, 7525-7530.
4. [4] Jantchou, P., Monnet, E., Carbonnel, F.: Environmental risk factors in Crohn's disease and ulcerative colitis (excluding tobacco and appendicectomy). Gastroenterol. Clin. Biol., 2006, 30, 859-867. (Pubitemid 44196107)
5. McGovern, D. P., van Heel, D. A., Ahmad, T. és mtsai: NOD2 (CARD15), the fi rst susceptibility gene for Crohn's disease. Gut, 2001, 49, 752-754.
6. Silverberg, M. S.: OCTNs: will the real IBD5 gene please stand up? World J. Gastroenterol., 2006, 12, 3678-3681.
7. Siminovitch, K. A.: Advances in the molecular dissection of infl ammatory bowel disease. Semin. Immunol., 2006, 18, 244-253.
8. Schreiber, S., Rosenstiel, P., Albrecht, M. és mtsai: Genetics of Crohn disease, an archetypal infl ammatory barrier disease. Nat. Rev. Genet., 2005, 6, 376-388.
9. Lesage, S., Zouali, H., Cezard, J. P. és mtsai: CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with infl ammatory bowel disease. Am. J. Hum. Genet., 2002, 70, 845-857.
10. Torkvist, L., Noble, C. L., Lordal, M. és mtsai: Contribution of the IBD5 locus to Crohn's disease in the Swedish population. Scand. J. Gastroenterol., 2007, 42, 200-206.
11. [11] Buning, C., Molnar, T., Nagy, F. és mtsai: NOD2/CARD15 gene polymorphism in patients with infl ammatory bowel disease: is Hungary different? World J. Gastroenterol., 2005, 11, 407-411. (Pubitemid 40125251)
12. Inoue, N., Tamura, K., Kinouchi, Y. és mtsai: Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology, 2002, 123, 86-91.
13. Leong, R. W., Armuzzi, A., Ahmad, T. és mtsai: NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment. Pharmacol. Ther., 2003, 17, 1465-1470.
14. Bene, J., Komlosi, K., Magyari, L. és mtsai: Plasma carnitine ester profi les in Crohn's disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes. Br. J. Nutr., 2007, 98, 345-350.
15. Tomer, G., Ceballos, C., Concepcion, E. és mtsai: NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Am. J. Gastroenterol., 2003, 98, 2479-2484.
16. Sun, L., Roesler, J., Rosen-Wolff, A. és mtsai: CARD15 genotype and phenotype analysis in 55 pediatric patients with Crohn disease from Saxony, Germany. J. Pediatr. Gastroenterol. Nutr., 2003, 37, 492-497.
17. Weiss, B., Shamir, R., Bujanover, Y. és mtsai: NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease. J. Pediatr., 2004, 145, 208-212.
18. Ferraris, A., Knafelz, D., Torres, B. és mtsai: Analysis of CARD15 gene variants in Italian pediatric patients with infl ammatory bowel diseases. J. Pediatr., 2005, 147, 272-273.
19. Bene, J., Magyari, L., Talian, G. és mtsai: Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease. World J. Gastroenterol., 2006, 12, 5550-5553.
20. Peltekova, V. D., Wintle, R. F., Rubin, L. A. és mtsai: Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet., 2004, 36, 471-475.
21. Torok, H. P., Glas, J., Tonenchi, L. és mtsai: Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut, 2005, 54, 1421-1427.
22. Newman, B., Gu, X., Wintle, R. és mtsai: A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster infl uences phenotypic expression of Crohn's disease. Gastroenterology, 2005, 128, 260-269.
23. Palmieri, O., Latiano, A., Valvano, R. és mtsai: Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment. Pharmacol. Ther., 2006, 23, 497-506.
24. Noble, C. L., Nimmo, E. R., Drummond, H. és mtsai: The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology, 2005, 129, 1854-1864.
25. Martinez, A., Martin, M. C., Mendoza, J. L. és mtsai: Association of the organic cation transporter OCTN genes with Crohn's disease in the Spanish population. Eur. J. Hum. Genet., 2006, 14, 222-226.
26. Tosa, M., Negoro, K., Kinouchi, Y. és mtsai: Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specifi c differences in infl ammatory bowel disease. Scand. J. Gastroenterol., 2006, 41, 48-53.
27. Vermeire, S., Pierik, M., Hlavaty, T. és mtsai: Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastro enterology, 2005, 129, 1845-1853.
28. Waller, S., Tremelling, M., Bredin, F. és mtsai: Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut, 2006, 55, 809-814.
29. Magyari, L., Bene, J., Komlosi, K. és mtsai: Prevalence of SLC22A4 1672T and SLC22A5 -207C combination defi ned TC haplotype in Hungarian ulcerative colitis patients. Pathol. Oncol. Res., 2007, 13, 53-56.
30. Nistico, L., Buzzetti, R., Pritchard, L. E. és mtsai: The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet., 1996, 5, 1075-1080.
31. Machida, H., Tsukamoto, K., Wen, C. Y. és mtsai: Association of polymorphic alleles of CTLA4 with infl ammatory bowel disease in the Japanese. World J. Gastroenterol., 2005, 11, 4188-4193.
32. Martin-Pagola, A., Perez, D. N., Vitoria, J. C. és mtsai: No association of CTLA4 gene with celiac disease in the Basque population. J. Pediatr. Gastroenterol. Nutr., 2003, 37, 142-145.
33. Naluai, A. T., Nilsson, S., Samuelsson, L. és mtsai: The CTLA4/ CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic infl ammatory disorders. Tiss. Antig., 2000, 56, 350-355.
34. Ahmedov, G., Ahmedova, L., Sedlakova, P. és mtsai: Genetic association of type 1 diabetes in an Azerbaijanian population: the HLA-DQ, -DRB1*04, the insulin gene, and CTLA4. Pediatr. Diabet., 2006, 7, 88-93.
35. Zalloua, P. A., Abchee, A., Shbaklo, H. és mtsai: Patients with early onset of type 1 diabetes have signifi cantly higher GG genotype at position 49 of the CTLA4 gene. Hum. Immunol., 2004, 65, 719-724.
36. Han, S., Zhang, S., Zhang, W. és mtsai: CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis. Hum. Immunol., 2006, 67, 618-626.
37. Vaidya, B., Oakes, E. J., Imrie, H. és mtsai: CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clin. Endocrinol. (Oxf), 2003, 58, 732-735.
38. Lee, C. S., Lee, Y. J., Liu, H. F. és mtsai: Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in Chinese. Clin. Rheumatol., 2003, 22, 221-224.
39. Lee, Y. H., Choi, S. J., Ji, J. D. és mtsai: No association of polymorphisms of the CTLA-4 exon 1(+49) and promoter(-318) genes with rheumatoid arthritis in the Korean population. Scand. J. Rheumatol., 2002, 31, 266-270.
40. Suppiah, V., Alloza, I., Heggarty, S. és mtsai: The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders. J. Neuroimmunol., 2005, 164, 148-153.
41. Xia, B., Crusius, J. B., Wu, J. és mtsai: CTLA4 gene polymorphisms in Dutch and Chinese patients with infl ammatory bowel disease. Scand. J. Gastroenterol., 2002, 37, 1296-1300.
42. Magyari, L., Farago, B., Bene, J. és mtsai: No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn's disease and ulcerative colitis in Hungarian population samples. World J. Gastroenterol., 2007, 13, 2205-2208.
43. Hue, S., Ahern, P., Buonocore, S. és mtsai: Interleukin-23 drives innate and T cell-mediated intestinal infl ammation. J. Exp. Med., 2006, 203, 2473-2483.
44. Iwakura, Y., Ishigame, H.: The IL-23/IL-17 axis in infl ammation. J. Clin. Invest., 2006, 116, 1218-1222.
45. McKenzie, B. S., Kastelein, R. A., Cua, D. J.: Understanding the IL-23-IL-17 immune pathway. Trends Immunol., 2006, 27, 17-23.
46. Duerr, R. H., Taylor, K. D., Brant, S. R. és mtsai: A genome-wide association study identifi es IL23R as an infl ammatory bowel disease gene. Science, 2006, 314, 1461-1463.
47. Farago, B., Magyari, L., Safrany, E. és mtsai: Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann. Rheum. Dis., 2007.
48. Arnott, I. D., Nimmo, E. R., Drummond, H. E. és mtsai: NOD2/ CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun., 2004, 5, 417-425. (Pubitemid 39139770)